- Home
- MNKD vs AHCO Comparison
MNKD vs AHCO Comparison
Compare MNKD & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- AHCO
- Stock Information
- Founded
- MNKD 1991
- AHCO N/A
- Country
- MNKD United States
- AHCO United States
- Employees
- MNKD N/A
- AHCO N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- AHCO Medical/Nursing Services
- Sector
- MNKD Health Care
- AHCO Health Care
- Exchange
- MNKD Nasdaq
- AHCO Nasdaq
- Market Cap
- MNKD 1.5B
- AHCO 1.3B
- IPO Year
- MNKD 2004
- AHCO N/A
- Fundamental
- Price
- MNKD $5.76
- AHCO $8.45
- Analyst Decision
- MNKD Buy
- AHCO Strong Buy
- Analyst Count
- MNKD 6
- AHCO 5
- Target Price
- MNKD $8.92
- AHCO $12.20
- AVG Volume (30 Days)
- MNKD 1.7M
- AHCO 966.8K
- Earning Date
- MNKD 02-26-2025
- AHCO 02-25-2025
- Dividend Yield
- MNKD N/A
- AHCO N/A
- EPS Growth
- MNKD N/A
- AHCO N/A
- EPS
- MNKD 0.08
- AHCO N/A
- Revenue
- MNKD $267,200,000.00
- AHCO $3,262,564,000.00
- Revenue This Year
- MNKD $44.15
- AHCO $3.06
- Revenue Next Year
- MNKD $19.65
- AHCO $2.97
- P/E Ratio
- MNKD $72.34
- AHCO N/A
- Revenue Growth
- MNKD 51.35
- AHCO 4.49
- 52 Week Low
- MNKD $3.47
- AHCO $7.25
- 52 Week High
- MNKD $7.63
- AHCO $11.90
- Technical
- Relative Strength Index (RSI)
- MNKD 48.03
- AHCO 29.42
- Support Level
- MNKD $5.32
- AHCO $8.58
- Resistance Level
- MNKD $5.65
- AHCO $9.10
- Average True Range (ATR)
- MNKD 0.18
- AHCO 0.40
- MACD
- MNKD 0.03
- AHCO -0.13
- Stochastic Oscillator
- MNKD 81.48
- AHCO 4.12
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.